1 unchanged sentence
Canton, Massachusetts;
−Removed: Éragny-sur-Epte, France;
+Added: Éragny-sur-Epte, France;
and Nanjing, China.
−Removed: We own or lease a total of 106 buildings at six locations in the U.S., France and China, that comprise 2.0 million square feet of manufacturing, research and development, distribution,
−Removed: packaging, laboratory, office and warehouse space.
−Removed: Our facilities are regularly inspected by the FDA in connection with our product approvals, and we believe that all of our facilities are being operated in material compliance with the FDA’s cGMP regulations.
+Added: We own or lease a total of 60 buildings at six locations in the U.S., France and China, that comprise 1.9 million square feet of manufacturing, research and development, distribution, packaging, laboratory, office and warehouse space.
+Added: Our facilities are regularly inspected by the FDA in connection with our product approvals, and we believe that all of our facilities are being operated in material compliance with the FDA’s cGMP regulations.
We continue to expand our facility in Nanjing, China and expect further significant investment.
−Removed: In April 2014, we acquired Merck’s API manufacturing business in Éragny-sur-Epte, France, which manufactures porcine insulin API and recombinant human insulin API, and expect to continue the current site activities.
+Added: In April 2014, we acquired Merck’s API manufacturing business in Éragny-sur-Epte, France, which manufactures porcine insulin API and recombinant human insulin API, and expect to continue the current site activities.
The following table provides a summary of our owned properties as of December 31, 2020:
4 unchanged sentences
Finished pharmaceutical products
−Removed: Éragny-sur-Epte, France
+Added: Éragny-sur-Epte, France
Manufacturing, laboratories, warehousing and administrative offices
23 unchanged sentences
We believe that our current manufacturing capacity is adequate for the near term.
−Removed: We have in the past approached capacity at one of our facilities largely as a result of the FDA’s request that we reintroduce certain previously discontinued products to help cope with a nationwide shortage of these products.
+Added: We have in the past approached capacity at one of our facilities largely as a result of the FDA’s request that we reintroduce certain previously discontinued products to help cope with a nationwide shortage of these products.
We believe that these capacity issues have been ameliorated as a result of certain other manufacturers re-entering the market and increasing the production of the products that were subject to the shortage.
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.